Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer
This study is currently recruiting participants.
Verified July 2012 by Mayo Clinic
Sponsor:
Mayo Clinic
Collaborator:
TapImmune, Inc.
Information provided by (Responsible Party):
Keith Knutson, Ph.D., Mayo Clinic
ClinicalTrials.gov Identifier:
NCT01632332
First received: June 28, 2012
Last updated: July 10, 2012
Last verified: July 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | June 2015 (Final data collection date for primary outcome measure) |